Patent: 9,707,153
✉ Email this page to a colleague
Summary for Patent: 9,707,153
Title: | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
Abstract: | The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine). |
Inventor(s): | Weeks; Wendell P. (Corning, NY), Schaut; Robert Anthony (Painted Post, NY), DeMartino; Steven Edward (Painted Post, NY), Peanasky; John Stephen (Big Flats, NY) |
Assignee: | Corning Incorporated (Corning, NY) |
Application Number: | 14/259,268 |
Patent Claims: | see list of patent claims |
Details for Patent 9,707,153
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Wyeth Pharmaceuticals Llc | PREVNAR 13 | pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) | Injection | 125324 | 02/24/2010 | ⤷ Try a Trial | 2033-04-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |